SC 13G Filing

Company

IGC Pharma, Inc.

Filed

January 21, 2009

Accession Number

0000950159-09-000219

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →